Because multiple peptides are involved, it becomes more difficult to attribute observed effects to any one component
We took a step back from traditional clinical datasets and asked a different question: What are patients actually saying about peptide therapy outside the clinic
In brain GSH measurements, different acquisition methodologies, internal references, and brain regions have been used
TB-500 Loading Phase Dose How long: 4 weeks for acute injuries, 6 weeks for chronic or post-surgical cases Dose: 2 to 2.5 mg subcutaneous, twice a week, on non-consecutive days (think Monday/Thursday or Tuesday/Friday) Weekly total: 4 to 5 mg Some people in the peptide community push higher, using 4 to 5 mg per injection, twice weekly (8 to 10 mg per week), for severe or long-standing injuries
Weeks 5 to 8 titrating to 5 to 7.5 mg